Breast cancer is the most common cancer in women worldwide. Despite technological advances, thousands of small, potentially curable cancers are not seen in dense mammograms. Ultrasound can find many of the small cancers missed by mammograms. However, ultrasound exams are limited due to operator’s dependency which can cause missing small cancers and inefficient, lengthy exams. Furthermore, most of the detected small lesions are not cancers, but the lack of diagnostic precision leads to unnecessary additional procedures, wasting billions of dollars. Metritrack’s unique solution eliminates multiple manual imprecise steps and enables the automated precise localization of breast ultrasound images, to avoid missing tumors, increase diagnostic precision, save time during scanning and interpretation and support high quality, standardized, exams. The patented, precise mapping method powers the only FDA cleared automated breast ultrasound system, the BVN G-1000, designed to precisely track small breast lesions during hand held breast ultrasound exams, without requiring operator’s input and not dependent on breast size or deformation.